Assessment of individual differences in the rat nucleus accumbens transcriptome following taste-heroin extended access

Brain Research Bulletin

Volumn 123, Issue , 2016, Pages 71-80

  Imperio, Caesar G ^a   McFalls, Ashley J ^a   Colechio, Elizabeth M ^a   Masser, Dustin R ^b,c   Vrana, Kent E ^a   Grigson, Patricia S ^a   Freeman, Willard M ^b,c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Heroin; Reward; RNA Seq; Transcription

Indexed keywords

DIAMORPHINE; MESSENGER RNA; SACCHARIN; SODIUM CHLORIDE; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; HEROIN DEPENDENCE; IMMUNITY; MALE; MOTIVATION; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RNA TRANSCRIPTION; TASTE; ANIMAL; ASSOCIATION; BRAIN; DRUG EFFECTS; DRUG SELF ADMINISTRATION; GENETICS; INDIVIDUALITY; INSTRUMENTAL CONDITIONING; METABOLISM; PHYSIOLOGY; REWARD; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; CONDITIONING, OPERANT; CUES; HEROIN; HEROIN DEPENDENCE; INDIVIDUALITY; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SACCHARIN; SELF ADMINISTRATION; TASTE; TASTE PERCEPTION; TRANSCRIPTOME;

EID: 84952342313     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2015.12.005     Document Type: Article

References (49)

1. Anders, S., Huber, W., Differential expression analysis for sequence count data. Genome Biol., 11, 2010, R106.
2. Bedard, A., Tremblay, P., Chernomoretz, A., Vallieres, L., Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation. Glia 55 (2007), 777–789.
3. Bell, R.L., Kimpel, M.W., McClintick, J.N., Strother, W.N., Carr, L.G., Liang, T., Rodd, Z.A., Mayfield, R.D., Edenberg, H.J., McBride, W.J., Gene expression changes in the nucleus accumbens of alcohol-preferring rats following chronic ethanol consumption. Pharmacol. Biochem. Behav. 94 (2009), 131–147.
4. Bixler, G.V., Vanguilder, H.D., Brucklacher, R.M., Kimball, S.R., Bronson, S.K., Freeman, W.M., Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. BMC Med. Genomics, 4, 2011, 40.
5. Casini, A., Vivacqua, G., Pontieri, F.E., Kimura, H., Bellier, J.P., D, L., ’Este, Renda, T.G., Choline acetyltransferase of the common type immunoreactivity in the rat brain following different heroin treatments: a pilot study. J. Chem. Neuroanat. 41 (2011), 111–121.
6. Cicero, T.J., Ellis, M.S., Surratt, H.L., Kurtz, S.P., The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA psychiatry 71 (2014), 821–826.
7. Faghihi, M.A., Wahlestedt, C., Regulatory roles of natural antisense transcripts. Nat. Rev. Mol. Cell Biol. 10 (2009), 637–643.
8. Faris, P.L., Opiate antagonistic function of cholecystokinin in analgesia and energy balance systems. Ann. N. Y. Acad. Sci. 448 (1985), 437–447.
9. Grigson, P.S., Hajnal, A., Once is too much: conditioned changes in accumbens dopamine following a single saccharin–morphine pairing. Behav. Neurosci. 121 (2007), 1234–1242.
10. Grigson, P.S., Twining, R.C., Cocaine-induced suppression of saccharin intake: a model of drug-induced devaluation of natural rewards. Behav. Neurosci. 116 (2002), 321–333.
11. Ikemoto, S., Panksepp, J., The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res. Brain Res. Rev. 31 (1999), 6–41.
12. Imperio, C.G., Grigson, P.S., Greater avoidance of a heroin-paired taste cue is associated with greater escalation of heroin self-administration in rats. Behav. Neurosci. 129 (2015), 380–388.
13. Kramer, A., Green, J., Pollard, J. Jr., Tugendreich, S., Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30 (2014), 523–530.
14. Kuntz, K.L., Patel, K.M., Grigson, P.S., Freeman, W.M., Vrana, K.E., Heroin self-administration: II. CNS gene expression following withdrawal and cue-induced drug-seeking behavior. Pharmacol. Biochem. Behav. 90 (2008), 349–356.
15. Kuntz, K.L., Twining, R.C., Baldwin, A.E., Vrana, K.E., Grigson, P.S., Heroin self-administration: I. Incubation of goal-directed behavior in rats. Pharmacol. Biochem. Behav. 90 (2008), 344–348.
16. Kuntz-Melcavage, K.L., Brucklacher, R.M., Grigson, P.S., Freeman, W.M., Vrana, K.E., Gene expression changes following extinction testing in a heroin behavioral incubation model. BMC Neurosci., 10, 2009, 95.
17. Lenoir, M., Cantin, L., Vanhille, N., Serre, F., Ahmed, S.H., Extended heroin access increases heroin choices over a potent nondrug alternative. Neuropsychopharmacology 38 (2013), 1209–1220.
18. Levine, A.S., Morley, J.E., Reduction of feeding in rats by calcitonin. Brain Res. 222 (1981), 187–191.
19. Liu, X., Wang, G., Pu, H., Jing, H., Abnormal intracellular calcium homeostasis associated with vulnerability in the nerve cells from heroin-dependent rat. Brain Res. 1572 (2014), 40–49.
20. Lohoff, F.W., Dahl, J.P., Ferraro, T.N., Arnold, S.E., Gallinat, J., Sander, T., Berrettini, W.H., Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. Neuropsychopharmacology 31 (2006), 2739–2747.
21. Luscher, C., Malenka, R.C., Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69 (2011), 650–663.
22. Manji, H.K., Lenox, R.H., Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol. Psychiatry 48 (2000), 518–530.
23. Masser, D.R., Berg, A.S., Freeman, W.M., Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing. Epigenet. Chromatin, 6, 2013, 33.
24. Masser, D.R., Bixler, G.V., Brucklacher, R.M., Yan, H., Giles, C.B., Wren, J.D., Sonntag, W.E., Freeman, W.M., Hippocampal subregions exhibit both distinct and shared transcriptomic responses to aging and nonneurodegenerative cognitive decline. J. Gerontol. A Biol. Sci. Med. Sci. 69 (2014), 1311–1324.
25. Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L., Wold, B., Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5 (2008), 621–628.
26. Multani, P.K., Hodge, R., Estevez, M.A., Abel, T., Kung, H., Alter, M., Brookshire, B., Lucki, I., Nall, A.H., Talbot, K., Doyle, G.A., Lohoff, F.W., VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination. Neuroscience 232 (2013), 32–44.
27. Nakagawa, S., Kim, J.E., Lee, R., Malberg, J.E., Chen, J., Steffen, C., Zhang, Y.J., Nestler, E.J., Duman, R.S., Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J. Neurosci. 22 (2002), 3673–3682.
28. Nestler, E.J., Cellular basis of memory for addiction. Dialogues Clin. Neurosci. 15 (2013), 431–443.
29. Passalacqua, K.D., Varadarajan, A., Weist, C., Ondov, B.D., Byrd, B., Read, T.D., Bergman, N.H., Strand-specific RNA-seq reveals ordered patterns of sense and antisense transcription in Bacillus anthracis. PLoS One, 7, 2012, e43350.
30. Pondel, M., Calcitonin and calcitonin receptors: bone and beyond. Int. J. Exp. Pathol. 81 (2000), 405–422.
31. Prossin, A.R., Zalcman, S.S., Heitzeg, M.M., Koch, A.E., Campbell, P.L., Phan, K.L., Stohler, C.S., Zubieta, J.K., Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans. Neuropsychopharmacology 40 (2015), 554–565.
32. Puhl, M.D., Boisvert, M., Guan, Z., Fang, J., Grigson, P.S., A novel model of chronic sleep restriction reveals an increase in the perceived incentive reward value of cocaine in high drug-taking rats. Pharmacol. Biochem. Behav. 109 (2013), 8–15.
33. Richards, M., Iijima, Y., Kondo, H., Shizuno, T., Hori, H., Arima, K., Saitoh, O., Kunugi, H., Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population. Behav. Brain Funct., 2, 2006, 39.
34. Robinson, M.D., Oshlack, A., A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol., 11, 2010, R25.
35. Saurer, T.B., Ijames, S.G., Carrigan, K.A., Lysle, D.T., Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain Behav. Immunol. 22 (2008), 89–97.
36. Schnur, P., Cesar, S.S., Foderaro, M.A., Kulkosky, P.J., Effects of cholecystokinin on morphine-elicited hyperactivity in hamsters. Pharmacol. Biochem. Behav. 39 (1991), 581–586.
37. Sultan, M., Dokel, S., Amstislavskiy, V., Wuttig, D., Sultmann, H., Lehrach, H., Yaspo, M.L., A simple strand-specific RNA-Seq library preparation protocol combining the illumina TruSeq RNA and the dUTP methods. Biochem. Biophys. Res. Commun. 422 (2012), 643–646.
38. Tamminga, C.A., Holcomb, H.H., Phenotype of schizophrenia: a review and formulation. Mol. Psychiatry 10 (2005), 27–39.
39. Tirumalai, P.S., Howells, R.D., Regulation of calbindin-D28K gene expression in response to acute and chronic morphine administration. Brain Res. Mol. Brain Res. 23 (1994), 144–150.
40. Trang, T., Koblic, P., Kawaja, M., Jhamandas, K., Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice. Neurosci. Lett. 451 (2009), 69–73.
41. Twining, R.C., Bolan, M., Grigson, P.S., Yoked delivery of cocaine is aversive and protects against the motivation for drug in rats. Behav. Neurosci. 123 (2009), 913–925.
42. S.A.a.M.H.S.A., 2012. U.S. Dept of Health and Human Services, Center for Behavioral Health Statistics and Quality, Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, in.
43. Wang, Z., Gerstein, M., Snyder, M., RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10 (2009), 57–63.
44. Wen, D., Cong, B., Ma, C., Yang, S., Yu, H., Ni, Z., Li, S., The effects of exogenous CCK-8 on the acquisition and expression of morphine-induced CPP. Neurosci. Lett. 510 (2012), 24–28.
45. Wetherill, L., Schuckit, M.A., Hesselbrock, V., Xuei, X., Liang, T., Dick, D.M., Kramer, J., Nurnberger, J.I. Jr., Tischfield, J.A., Porjesz, B., Edenberg, H.J., Foroud, T., Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcohol Clin. Exp. Res. 32 (2008), 2031–2040.
46. Wheeler, R.A., Twining, R.C., Jones, J.L., Slater, J.M., Grigson, P.S., Carelli, R.M., Behavioral and electrophysiological indices of negative affect predict cocaine self-administration. Neuron 57 (2008), 774–785.
47. Wheeler, R.A., Aragona, B.J., Fuhrmann, K.A., Jones, J.L., Day, J.J., Cacciapaglia, F., Wightman, R.M., Carelli, R.M., Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state. Biol. Psychiatry 69 (2011), 1067–1074.
48. Williams, K.W., Elmquist, J.K., From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat. Neurosci. 15 (2012), 1350–1355.
49. Zhou, Y., Leri, F., Cummins, E., Kreek, M.J., Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats. Physiol. Behav. 139 (2015), 127–135.